American Association for Cancer Research: An Exosome-Based Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer
April 09, 2024
April 09, 2024
SAN DIEGO, California, April 9 (TNSres) -- The American Association for Cancer Research issued the following news release:
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.
"Pancreatic cancer is one of the most fatal malignancies, in large part beca . . .
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.
"Pancreatic cancer is one of the most fatal malignancies, in large part beca . . .